{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-035696","form_type":"8-K","ticker":null,"cik":"0001839133","company_name":"IR-Med, Inc.","filed_at":"2023-10-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.935278+00:00","generated_at":"2026-06-10T04:58:24.011317+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"IR-Med appoints healthcare exec Tzur Di-Cori as CEO; PressureSafe commercial launch pending approval","bullets":["Tzur Di-Cori appointed CEO effective Oct 15, 2023; previously President/CEO of LifeWatch Technologies and other healthcare firms.","Receives monthly salary of NIS 45,000 (~$11,842) and options for 1,000,000 shares at $0.58, vesting over 4 years.","Chairman Oded Bashan remains Chairman; commercial launch of PressureSafe expected in current quarter pending regulatory approval.","Di-Cori's previous roles include CEO of Motorika Medical, Veoli, DUSMIT; no family relationships with directors."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-035696","json":"https://secwatch.observer/filing/0001493152-23-035696.json","markdown":"https://secwatch.observer/filing/0001493152-23-035696.md","text":"https://secwatch.observer/filing/0001493152-23-035696.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1839133/000149315223035696/0001493152-23-035696-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1839133/000149315223035696/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T04:58:24.011317+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"41badef34e","claim":"Tzur Di-Cori was appointed as Chief Executive Officer at IR-Med, Inc..","evidence_excerpt":"Effective as of October 15, 2023, the board of directors (the “Board”) of IR-Med, Inc. (the “Company”) appointed Mr. Tzur Di-Cori to serve as its Chief Executive Officer (CEO), effective October 15, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1839133/000149315223035696/0001493152-23-035696-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}